Alan Lee Landay

Title: Alan Lee Landay: Inventor in Medical Research

Introduction

Alan Lee Landay is an inventor associated with The Macfarlane Burnet Institute for Medical Research and Public Health Limited in Melbourne, Australia. His patent work concerns antibody capture and diagnostic approaches involving immunoglobulins.

Latest Patents

The supplied information identifies one patent for Landay: “Diagnostic, prognostic, therapeutic and screening protocols.” The specification describes capturing dIgA from a biological sample by contacting it with recombinant pIgR, or a dIgA-binding variant, to form a pIgR-dIgA complex. The complex, or a complex involving the captured dIgA and an antigen of interest, may then be assessed.

The patent also describes a process for evaluating gut wall integrity by comparing the level or ratio of SIgA to dIgA in a test subject with that of a control subject. It further covers related kits and the use of recombinant pIgR to capture or detect dIgA and/or IgM. Landay is credited with 1 patent in the information provided.

Career Highlights

Landay’s listed patent reflects work at the intersection of immunology and diagnostic testing. Its proposed methods use antibody-binding interactions to support assessment and screening, including the evaluation of gut wall integrity.

Collaborations

The supplied information lists Mary Louise Garcia and Nadine Carmel Barnes as Landay’s coworkers. His associated organization is The Macfarlane Burnet Institute for Medical Research and Public Health Limited.

Conclusion

Alan Lee Landay’s listed invention focuses on pIgR-based antibody capture and diagnostic protocols, with potential applications in detecting immunoglobulins and assessing gut wall integrity.